HIM
NVO

Harbour Investment Management’s Novo Nordisk NVO Stock Holding History

Harbour Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Sell
47,650
-70
-0.1% -$3.01K 1.18% 23
2026
Q1 		$1.81M Sell
47,720
-8,760
-16% -$415K 0.98% 29
2025
Q4 		$2.87M Sell
56,480
-18,121
-24% -$927K 1.52% 17
2025
Q3 		$4.14M Sell
74,601
-7,860
-10% -$460K 1.8% 14
2025
Q2 		$5.69M Sell
82,461
-1,000
-1% -$68K 2.46% 8
2025
Q1 		$5.89M Sell
83,461
-450
-0.5% -$37.2K 2.66% 6
2024
Q4 		$7.22M Sell
83,911
-640
-0.8% -$69.2K 3.17% 5
2024
Q3 		$10.1M Sell
84,551
-4,215
-5% -$562K 4.46% 4
2024
Q2 		$12.7M Sell
88,766
-3,824
-4% -$507K 5.85% 3
2024
Q1 		$12M Sell
92,590
-1,200
-1% -$143K 5.62% 3
2023
Q4 		$9.7M Sell
93,790
-2,420
-3% -$239K 5.06% 4
2023
Q3 		$8.75M Sell
96,210
-2,690
-3% -$237K 5% 4
2023
Q2 		$8M Sell
98,900
-1,992
-2% -$163K 4.21% 4
2023
Q1 		$8.09M Sell
100,892
-220
-0.2% -$15.6K 4.48% 4
2022
Q4 		$6.84M Sell
101,112
-1,700
-2% -$99.7K 3.94% 4
2022
Q3 		$5.12M Sell
102,812
-460
-0.4% -$24.6K 3.21% 4
2022
Q2 		$5.75M Sell
103,272
-2,460
-2% -$137K 3.46% 4
2022
Q1 		$5.87M Sell
105,732
-2,012
-2% -$103K 2.85% 6
2021
Q4 		$6.03M Sell
107,744
-200
-0.2% -$10.8K 2.75% 7
2021
Q3 		$5.18M Sell
107,944
-840
-0.8% -$40.6K 2.63% 9
2021
Q2 		$4.56M Buy
108,784
+1,796
+2% +$69.6K 2.28% 9
2021
Q1 		$3.61M Sell
106,988
-1,340
-1% -$47.7K 1.92% 18
2020
Q4 		$3.78M Hold
108,328
– – 2.11% 12
2020
Q3 		$3.76M Buy
108,328
+3,154
+3% +$105K 2.33% 8
2020
Q2 		$3.44M Sell
105,174
-3,000
-3% -$95.7K 2.4% 8
2020
Q1 		$3.26M Sell
108,174
-340
-0.3% -$10.1K 2.61% 8
2019
Q4 		$3.14M Sell
108,514
-166
-0.2% -$4.6K 2.07% 14
2019
Q3 		$2.81M Sell
108,680
-1,100
-1% -$27.8K 1.99% 16
2019
Q2 		$2.8M Sell
109,780
-640
-0.6% -$15.8K 1.98% 16
2019
Q1 		$2.89M Sell
110,420
-2,450
-2% -$60.2K 2.13% 15
2018
Q4 		$2.6M Sell
112,870
-1,650
-1% -$36.7K 2.14% 14
2018
Q3 		$2.7M Sell
114,520
-600
-0.5% -$14.6K 1.97% 19
2018
Q2 		$2.65M Sell
115,120
-2,470
-2% -$58.7K 2.08% 14
2018
Q1 		$2.9M Sell
117,590
-2,530
-2% -$66.4K 2.16% 12
2017
Q4 		$3.22M Sell
120,120
-16,440
-12% -$418K 2.27% 7
2017
Q3 		$3.29M Sell
136,560
-2,800
-2% -$63.3K 2.3% 7
2017
Q2 		$2.99M Buy
139,360
+2,300
+2% +$46.4K 2.18% 12
2017
Q1 		$2.35M Sell
137,060
-600
-0.4% -$10.4K 1.74% 19
2016
Q4 		$2.47M Sell
137,660
-2,510
-2% -$45.5K 1.87% 16
2016
Q3 		$2.92M Buy
140,170
+10,850
+8% +$269K 2.23% 11
2016
Q2 		$3.48M Buy
129,320
+810
+0.6% +$22.2K 2.66% 6
2016
Q1 		$3.48M Buy
128,510
+800
+0.6% +$21.4K 2.68% 8
2015
Q4 		$3.71M Sell
127,710
-5,450
-4% -$151K 2.89% 7
2015
Q3 		$3.61M Buy
133,160
+250
+0.2% +$7.08K 2.91% 7
2015
Q2 		$3.64M Sell
132,910
-3,570
-3% -$100K 2.73% 8
2015
Q1 		$3.64M Sell
136,480
-17,900
-12% -$412K 2.68% 7
2014
Q4 		$3.27M Sell
154,380
-100
-0.1% -$2.23K 2.06% 12
2014
Q3 		$3.68M Sell
154,480
-1,150
-0.7% -$26.5K 2.45% 9
2014
Q2 		$3.59M Sell
155,630
-5,800
-4% -$128K 2.29% 10
2014
Q1 		$3.69M Sell
161,430
-3,300
-2% -$70.3K 2.41% 10
2013
Q4 		$3.04M Sell
164,730
-18,300
-10% -$319K 2.04% 13
2013
Q3 		$3.1M Sell
183,030
-250
-0.1% -$4.21K 2.16% 11
2013
Q2 		$2.84M Buy
+183,280
New +$3.05M 2.08% 12

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Harbour Investment Management's NVO Position: Q2 2026 in Review

Harbour Investment Management reduced its Novo Nordisk (NVO) stake by 0.15% in Q2 2026, selling an estimated $3.01K and leaving 47,650 shares worth $2.28M. The position accounts for 1.18% of the portfolio, ranked #23.

Harbour Investment Management first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.7M in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Harbour Investment Management held 47,650 shares of Novo Nordisk worth $2.28M as of Q2 2026.
  • Harbour Investment Management sold 70 Novo Nordisk shares in Q2 2026, an estimated $3.01K.
  • Novo Nordisk made up 1.18% of Harbour Investment Management's portfolio in Q2 2026, its #23 holding.
  • Harbour Investment Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Harbour Investment Management's Novo Nordisk position peaked at $12.7M in Q2 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Harbour Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.